Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Renren Inc., China's biggest networking website by page views, is discussed by Yoshikami with Emily Chang and Cory Johnson on 'Bloomberg West'.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joseph Chen and Chen Ji are the CEOs of Renren
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Blending Quantitative Precision and Trading Experience to Navigate Japan’s Markets with Systematic Edge|Aman Oberoi,CEO,K2Q Capital
00:10:00
Deciphering Investment Opportunities: Andrew Clifford's Approach | Andrew Clifford , CEO , Platinum Asset Management.
00:10:00
How Foster & Motley Formed: A Journey from Solo Ventures to a Successful Partnership
00:10:00
On the hunt for dynamic teams with sound fundamentals building market-leading consumer brands.|Jordan Gaspar,Managing Partner,AF Ventures
00:10:00
"Factoring transforms invoices into immediate cash, offering fast payment solutions and benefits for trucking companies."
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:10:00
NuScale CEO John Hopkins discusses nuclear energy advancements and the company's innovative solutions at the Nuclear Energy Assembly.
00:10:00
David Bramhill at 121 Oil & Gas Investment London: Insights into Union Jack Oil's Strategy and Market Position | David Bramhill, Executive Chairman, Union Jack Oil Plc.
00:10:00
From Intel Intern to Food Tech Visionary: Funding, Challenges|Brian Frank,General Partner,FTW Ventures
00:10:00
Kirkland's Open Assignment System|Lauren O. Casazza, Partner,Kirkland & Ellis
00:10:00
Abercrombie & Fitch CEO Fran Horowitz on Efficiency and Adaptation Post-COVID | Fran Horowitz, CEO , Abercrombie & Fitch Co.
00:10:00
Pioneers the Inclusive Investing (TM) strategy to address racial wealth|Nasir Qadree,Founder and Managing Partner,Zeal Capital Partners